Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation.
Data linking in vivo platelet activation with inflammation and cardiovascular risk factors are scarce. Moreover, the interrelation between endothelial dysfunction as early marker of atherosclerosis and platelet activation has not been studied, so far. We therefore sought to investigate the associati...
Main Authors: | Thomas Gremmel, Thomas Perkmann, Christoph W Kopp, Daniela Seidinger, Beate Eichelberger, Renate Koppensteiner, Sabine Steiner, Simon Panzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4373671?pdf=render |
Similar Items
-
Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
by: Stefan Stojkovic, et al.
Published: (2020-12-01) -
Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
by: Thomas Gremmel, et al.
Published: (2015-01-01) -
Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
by: Silvia Lee, et al.
Published: (2018-09-01) -
Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
by: Silvia Lee, et al.
Published: (2020-06-01) -
Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
by: Svitlana Demyanets, et al.
Published: (2020-01-01)